Objective: The aim of this study was to investigate the effects of different phytosterols and their analogs on colonic mucosal cell proliferation in hamsters. Method: Hamsters (n = 70) were randomly assigned to seven groups after a 2-week acclimation and fed the experimental diet for 5 weeks. Diets included (i) the semipurified diet with no cholesterol (Con), (ii) the Con diet plus 0.25% cholesterol (Ch-con), or the Ch-con diet with (iii) 1% phytosterols (Ste), (iv) 1% phytostanols (Sta), (v) 1.76% sterol esters (esterified to fish oil, SteF), (vi) 0.71% stanol esters (esterified to ascorbic acid [disodium ascorbyl phytostanol phosphate, FM-VP4], 0.7% StaA) and (vii) 1.43% stanol esters (1.4% StaA), respectively. After 5 weeks on experimental diet, hamsters were sacrificed, and colons were collected. Colonic mucosal cell proliferation was measured by immunohistochemistry using monoclonal antibodies against antigen Ki-67. Results: Colonic mucosal cell proliferation was 21.4% ( P b.01) lower in the 0.7%, but not 1.4%, StaA relative to the Ch-con group. In addition, a lower (À13.9%) cell proliferation was observed in the SteF group in comparison to the Ch-con group; however, this difference achieved only a borderline level of statistical significance ( P = .069). No differences were observed between Con and Ch-con, as well as among Ste, Sta, 1.4% StaA and Ch-con treatments. Conclusion: Plant stanols esterified to ascorbic acid may possess anticarcinogenic properties in the colon by suppressing colonic mucosa cell proliferation; however, this effect was not observed with free plant sterols or stanols. D
Introduction
The interest in studying plant sterols (PS) was initiated from findings that PS can reduce plasma total cholesterol and low-density lipoprotein cholesterol levels, and thus offer a protection against cardiovascular disease [1] [2] [3] [4] [5] [6] [7] . Recent evidence indicates that consumption of PS, apart from lowering cholesterol levels, also provides protection against certain cancers, such as colon cancer [8 -10] . It has been suggested that the inhibition of colonic mucosal cell proliferation by PS is associated with a lower risk of colon cancer development [11] . Dietary supplementation of sitosterol resulted in a 39% reduction in the number of rats that developed methylnitrosourea-induced tumors and a 60% reduction of tumor cells per rat, in comparison to controls [8] . Consistently, in vitro studies have shown an inhibitory effect of h-sitosterol on the growth of HT-29 cells, a human colon cancer cell line, after 5 days of incubation in a medium containing h-sitosterol at 16 Amol/L [9] . Similarly, Awad et al. [10] reported that feeding rats with a diet containing 2% PS resulted in the normalization of cholic acid-induced hyperproliferation of colonocytes. Recent studies suggest that antioxidants, such as vitamins C and E, can enhance the chemotherapeutic efficacy of antitumor agents [12, 13] , raising the question of whether vitamin C can work synergistically with PS to reduce cancer development in the colon.
In addition, epidemiological and experimental evidence has demonstrated that n-3 polyunsaturated fatty acids (PUFA) can protect the colon from cancer development. consume higher levels of n-3 PUFA than other North Americans and have lower rates of colon cancer [14 -16] . An inverse relationship has been reported between fish or fish oil consumption and the risk of colorectal cancer [17, 18] . The inhibitory effect of n-3 PUFA on colon cancer has been confirmed by results from several laboratory studies in rodents, supplemented with either eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) [19 -22] . However, it is not known whether plant sterols esterified to n-3 PUFA can provide added protection against colon cancer development.
The objectives of the present study were, therefore, to investigate the effects of dietary supplementation with different PS analogs, including plant sterols, stanols, sterols esterified to n-3 fatty acids of fish oil and stanols esterified to ascorbic acid on colonic mucosal cell proliferation in hamsters.
Materials and methods

Animals and diets
Seventy male golden Syrian hamsters, weighing 100-120 g (Charles River Laboratories, Montreal, QC, Canada), were housed individually in stainless steel mesh cages and subjected to a 12:12 light/dark cycle. Animals were fed a regular rodent chow with free access to diet and water. After 2 weeks of adaptation, hamsters were randomly divided into seven groups and fed the experimental diets for 5 weeks. Group 1 was given a semipurified corn starchcasein-sucrose diet with no cholesterol (Con). Group 2 was given the Con diet plus 0.25% cholesterol (Ch-con). The remaining five groups were given the Ch-con diet containing either 1% phytosterols (Ste), 1% phytostanols (Sta), 1.76% sterol esters (esterified to fish oil, SteF), 0.71% stanol esters (esterified to ascorbic acid [disodium ascorbyl phytostanol phosphate, FM-VP4], 0.7% StaA) or 1.43% stanol esters (1.4% StaA). Each diet contained 5% oil, in the form of a mixture of beef tallow and safflower oil, to provide a polyunsaturated to saturated fatty acids ratio of 0.4. Composition of the experimental diets is presented in Table 1 . The SteF diet contained the same amount of plant sterols as the Ste diet. Diets containing 0.7% and 1.4% StaA provided 0.5% and 1% free plant stanols, respectively. Plant sterol analogs were mixed into the oil by heating at 558C before blending into diets. Diets were prepared every 2 weeks and stored at À208C.
After 5 weeks of experimental diet feeding, hamsters were anaesthetized with halothane and killed by decapitation. Colons were removed, flushed twice with phosphatebuffered saline (PBS, pH 7.4) and fixed in 10% neutral buffered formalin.
The experiment was reviewed and approved by the Animal Care and Research Ethics Committee of McGill University and was conducted in accordance with the guidelines of the Canadian Council on Animal Care.
Measurement of colon cell proliferation
The formalin-fixed colon tissues were embedded in paraffin and cut into slices at a thickness of 5 Am and dried at 608C for 1 h. Slides were deparaffinized with xylene and rehydrated using graded alcohols. Endogenous peroxidase was quenched with 3% H 2 O 2 for 15 min and washed with PBS containing Triton (PBST). Antigens were retrieved with citrate buffer (pH 6.0) and microwaved twice with 10 min each, allowed to cool for 15 min and washed with PBST. The slides were then placed on an autostainer, washed with PBST and blocked with PBST containing 0.03% casein at room temperature for 30 min. The primary antibody Ki-67 (Novus Biologicals, Littleton, CO, USA) 
1.43 a Con: non-cholesterol control diet; Ch-con: cholesterol control diet which was the non-cholesterol control diet with 0.25% cholesterol added; Ste: cholesterol control diet with 1% plant sterols added; Sta: cholesterol control diet with 1% plant stanols added; 1.76% SteF: cholesterol control diet with 1.76% sterol esterified to fish oil added; 0.7% and 1.4% StaA: cholesterol control diet with 0.71% or 1.43% stanol esterified with ascorbate added.
b SteF: plant sterols esterified to fish oil; 1.76% SteF contains an equivalent amount of 1% unesterified phytosterols. c StaA: plant stanols esterified to ascorbate; 0.7% and 1.4% StaA contain an equivalent amount of 0.5% and 1.0% unesterified phytostanols, respectively. was diluted by 1:100 with PBS and applied to the slides, which were then incubated at room temperature for 1 h. Rabbit IgG was used as isotype-matched negative control. After washing with PBST, the slides were incubated with biotinylated secondary antibody (goat antirabbit IgG) at room temperature for 30 min. The slides were washed with PBST and treated with an avidin-biotinylated antibody complex (Vector Labs, Burlingame, CA, USA). After 30 min, the slides were washed with PBST and treated with chromogen 3,3V-diaminobenzidine tetrahydrochloride (DAKO, Carpinteria, CA, USA) for 5 min. The counterstain was performed with hematoxylin, and the slides were dehydrated, cleaned and covered with glass lids. Proliferative cells are Ki-67 positive showing distinctively brown stains and were counted using a microscope. For each slide, colonocytes of 10 well-oriented crypts (longitudinal section) were counted. The colonic mucosal cell proliferation was expressed as a labeling index, i.e., the ratio of the number of Ki-67-positive cells to the total number of colonocytes [10] .
Data analysis and statistics
Data are presented as meansFS.E.M. One-way ANOVA was used to determine whether there was a significant treatment effect. When a significant ANOVA was obtained, the method of least squares means test was applied to test the differences between treatments. All statistical computations were done using the general linear model procedure of the SAS software [23] , and the statistical significance level was set at P b.05.
Results
Body weight and food consumption
No significant difference was observed among the treatment groups for the beginning and final body weights, respectively, after the 5-week feeding period. Similarly, there were no significant differences among the groups in the average or total food intake during the last 2-week period.
Colon mucosal cell proliferation analysis
The immunohistochemistry technique for labeling proliferative colonocytes with antibody Ki-67 is demonstrated in Fig. 1 . Cells at G 1 ,S,G 2 or M phases are considered to be proliferative and identified by positive binding with Ki-67 monoclonal antibodies. Those cells bearing a dark-brown stain are proliferative cells and are distinct from the nonproliferative cells.
As shown in Fig. 2 , colon cell proliferation did not differ between Con and Ch-con groups. A decrease ( P b.01) in colon cell proliferation was observed in animals given 0.7% StaA as compared with those fed the Ch-con diet. Surprisingly, animals fed 1.4% StaA did not show further inhibition of colon cell proliferation as compared to those fed 0.7% StaA. Hamsters fed SteF tended to have a lower (À13.9%) proliferation rate of colonocytes relative to those given the Ch-con diet; however, the difference was of borderline significance ( P = .069). No differences were detected between the Con and Ch-con treatments, or among the other groups.
Discussion
Results of the present study demonstrate for the first time that plant stanols esterified to ascorbic acid may inhibit colonic mucosal cell proliferation under normal physiological conditions in hamsters fed an atherogenic diet. It is surprising that the lower dose (0.7%) of stanol esters showed a stronger effect than the higher dose (1.4%), since it has been anticipated that plant stanol esters would produce an inhibitory effect on colon cancer development in a dosedependent manner. Feeding hamsters with plant sterol esters showed an inhibitory effect on colon mucosal cell proliferation at a marginal level of statistical significance, which was in agreement, to a certain extent, with the results of previous studies [18, 24, 25] . Free sterols and stanols did not show any effect on the proliferation of colonic mucosal cells, which contradict the results of previous animal studies [8, 10, 26] that PS showed significant inhibitory effects on colon mucosal cell proliferation. The discrepancy may be due to the differences in experimental conditions since early studies examined the effects of PS on the proliferation of colon tumors induced by oral administration of either chemical carcinogens [8] or cholic acid [10, 26] . Results of these studies also suggest that plant sterols may inhibit the proliferation of colon tumor cells or stimulated colon mucosal cells, but do not affect the proliferation of healthy colon mucosal cells. Although high dietary cholesterol was considered as a bstimulatorQ of colon mucosal cell proliferation, no effect was indeed observed.
It is known that ascorbic acid has antioxidant activities in the presence of oxidative stress, such as inflammation [27] . Ascorbic acid enhances the chemotherapeutic effect of cyclophosphamide, vinblastine and doxorubicin in mice when supplemented at a dose of 500 mg/kg per day [28] , while showing no effect when administered at a high dose of 2 g/kg per day [29] . Ascorbic acid possesses not only antioxidant activity but also pro-oxidant properties, although the latter effect remains controversial [30 -34] .A recent study [34] showed that ascorbic acid increases prooxidant effect in a dose-dependent manner in macrophages. Data of these early published studies may partly explain the paradoxical results observed in the current study, i.e., ascorbate in StaA functioned as an anti-oxidant at the dose of 0.7% and enhanced the antitumor property of phytostanols, while acting as a pro-oxidant at the higher dose of 1.4% and resulted in the loss of inhibitory effect of StaA on colonic mucosal cell proliferation. Since ascorbic acid was not tested separately in the current study, it is impossible to elucidate whether the enhanced inhibitory effect of stanol esters was simply a result of increased bioavailability of phytostanols or due to a synergistic action of phytostanols and ascorbic acid.
Balance between proliferation and apoptosis determines tumor development and growth. An early study [24] assessed both proliferation and apoptosis in the colonic crypts of rats exposed to azoxymethane and fed with either a high corn-oil diet or a high fish-oil diet. Results showed that n-3 PUFA consumption suppressed tumor growth by increasing apoptosis instead of inhibiting cell proliferation. Later, two other studies [20, 25] in rats showed that n-3 PUFA in fish oil inhibited the proliferation and promoted the apoptosis of normal colonic mucosa cells and cells in 1,2-dimethylhydrazine-induced aberrant colonic crypts. Present results showed a tendency ( P = .069) of inhibiting normal colonic mucosa cell proliferation by sterols esterified to n-3 PUFA in fish oil, while PS alone did not show any effect. It is implied that fish oil possesses a potential to inhibit colon mucosal cell proliferation. Further studies are required to assess the potential of SteF as a dietary chemopreventive agent, including cell proliferation, apoptosis and differentiation.
High circulating cholesterol levels may favor cancer development because they increase the gene expression of cholesterol 7a-hydroxylase, the first and rate-limiting enzyme in bile acid synthetic pathway, and thus increase the secretion of bile acids, particularly cholic acid [35] . Cholic acid has been reported to be a cancer inducer [10] . However, few studies have been conducted to examine whether cholesterol is a stimulator of colon cancer. Our current findings did not reveal any effect of cholesterol on the cell Fig. 2 . Effects of different phytosterol analogs on normal colonic mucosal cell proliferation in hamsters. Data across treatment groups were analyzed by one-way ANOVA. Where a significance level of less than .05 was achieved; differences between group means were evaluated using the least squares means test. Data are presented as meansFS.E.M. (n = 10). Values with different letters are significantly different ( P b.05). Con: non-cholesterol control diet; Ch-control: cholesterol-added diet; Ste: cholesterol-and phytosterol-added diet; Sta: cholesterol-and phytostanol-added diet; SteF: cholesterol and phytosterols esterified to fish oiladded diets; 0.7% and 1.4% StaA: cholesterol and phytostanols esterified to ascorbate-added diets.
proliferation of colonic mucosa; indicating that the cholesterol level used in the current study may not be high enough to increase cholic acid concentration to the level that passes the colon and stimulate the colon mucosal cell proliferation.
In summary, dietary supplementation of stanol esterified with ascorbic acid at the lower dose significantly inhibited colon cell proliferation rate, and sterol esterified with n-3 PUFA in fish oil showed a trend of inhibiting colonic cell proliferation. Free sterols and stanols did not affect colonic mucosal cell proliferation under normal physiological conditions. Dietary cholesterol at the dose of the present study did not show any effect on colonic mucosal cell proliferation. Our results implicated that plant sterol esters and stanol esters may possess capabilities to protect or delay cancer development in the colon.
